The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy (Q45125131)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy |
scientific article published in November 2004 |
Statements
1 reference
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy (English)
1 reference
Gabriel N Hortobagyi
1 reference
Elizabeth J Shpall
1 reference
Richard E Champlin
1 reference
Roy Jones
1 reference
Yee Chung Cheng
1 reference
Gabriela Rondón
1 reference
Ying Yang
1 reference
Terry L Smith
1 reference
James L Gajewski
1 reference
Michele L Donato
1 reference
Naoto T Ueno
1 reference
1 November 2004
1 reference
1 reference
10
1 reference
11
1 reference
794-804
1 reference
Identifiers
1 reference
1 reference